about
Met and its ligand HGF are associated with clinical outcome in breast cancer.Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.ene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumabPTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancerThe effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cynthia Veenstra
@ast
Cynthia Veenstra
@en
Cynthia Veenstra
@es
Cynthia Veenstra
@nl
type
label
Cynthia Veenstra
@ast
Cynthia Veenstra
@en
Cynthia Veenstra
@es
Cynthia Veenstra
@nl
prefLabel
Cynthia Veenstra
@ast
Cynthia Veenstra
@en
Cynthia Veenstra
@es
Cynthia Veenstra
@nl
P106
P31
P496
0000-0002-3084-7881